Inactive Instrument
Intervacc AB (publ) Stock Nasdaq Stockholm
Stocks
SE0009607252
Biotechnology & Medical Research
| Market Cap | 443M 45.63M 40.08M 36.93M 34.53M 64.76M 4.31B 65.95M 172M 2.12B 171M 168M 7.38B | P/E 2026 * |
-5.42x | P/E 2027 * | -5.42x |
|---|---|---|---|---|---|
| Enterprise Value | 356M 36.67M 32.21M 29.68M 27.75M 52.04M 3.46B 53M 138M 1.71B 138M 135M 5.93B | EV / Sales 2026 * |
22.3x | EV / Sales 2027 * | 11.6x |
| Free-Float |
80.66% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -2.15% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 70 | 2026-02-04 | |
Jan Persson
DFI | Director of Finance/CFO | - | 2020-02-05 |
Andrew Waller
CTO | Chief Tech/Sci/R&D Officer | - | 2020-06-10 |
| Director | Title | Age | Since |
|---|---|---|---|
Emil Billbäck
CHM | Chairman | 56 | 2026-05-12 |
| Director/Board Member | 72 | 2023-12-31 | |
| Director/Board Member | 68 | 2024-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.15% | -1.02% | - | - | 45.63M | |
| +0.72% | +1.76% | +64.66% | +119.94% | 55.35B | |
| +1.58% | +14.12% | +72.87% | +85.18% | 51.92B | |
| +0.12% | -0.02% | -15.05% | -15.67% | 22.76B | |
| +3.19% | +8.78% | +5.43% | +438.75% | 22.64B | |
| -0.18% | +7.20% | +28.56% | -12.48% | 17.36B | |
| -1.10% | +3.70% | +28.32% | -34.71% | 16.1B | |
| -3.35% | +8.96% | +135.18% | +294.38% | 13.96B | |
| +2.87% | +6.60% | +27.04% | +181.29% | 13.38B | |
| +1.31% | +0.53% | +27.21% | - | 12.27B | |
| Average | +0.30% | +5.01% | +41.58% | +132.09% | 25.08B | |
| Weighted average by Cap. | +0.81% | +6.10% | +47.30% | +123.67% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16M 1.65M 1.45M 1.33M 1.25M 2.34M 155M 2.38M 6.2M 76.64M 6.19M 6.05M 266M | 30M 3.09M 2.71M 2.5M 2.34M 4.38M 292M 4.47M 11.62M 144M 11.6M 11.35M 499M |
| Net income | -81.6M -8.4M -7.38M -6.8M -6.36M -11.93M -793M -12.15M -31.61M -391M -31.56M -30.87M -1.36B | -83.3M -8.58M -7.54M -6.94M -6.49M -12.18M -809M -12.4M -32.27M -399M -32.22M -31.51M -1.39B |
| Net Debt | -87M -8.96M -7.87M -7.25M -6.78M -12.72M -845M -12.95M -33.7M -417M -33.65M -32.91M -1.45B | -96M -9.89M -8.68M -8M -7.48M -14.03M -933M -14.29M -37.18M -460M -37.13M -36.31M -1.6B |
Employees
-
Calendar
